How long should bisphosphonate treatment be maintained in patients with osteoporosis after aromatase inhibitor therapy?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18850451
Cited by: 0

Abstract

Bisphosphonate therapy duration post-AI therapy often ranges from 3 to 5 years, tailored to fracture risk and patient-specific factors, with no substantial evidence supporting benefits beyond this period.

Fields of Study & Subjects

Bone health and osteoporosis research Bone health and treatments Menopause: Health Impacts and Treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
3 March 2026
Language
EN